Paracetamol is an effective analgesic but its mechanism of action is unclear. We investigated the effect of paracetamol and the analgesic adjuvant caffeine on the activity of NO synthase in mouse spinal cord and cerebellar slices in vitro, by measuring the conversion of [
Introduction
Paracetamol has been used as an over-the-counter analgesic for several years, although its mechanism of action is still not completely understood (Prescott, 2001; Simmons et al., 2004; Kis et al., 2005) . It has been suggested (Bjorkman, 1994) ester (L-NAME) blocks thermal hyperalgesia and the nociceptive response to formalin in rats and mice, and this effect is reversed by the administration of the NO precursor Larginine (Kitto et al., 1992; Malmberg and Yaksh, 1993; Yamamoto and Shimoyama, 1995; Sakurada et al., 2001) . Nociception induced by acetic acid in the writhing test in mice, has also been found to be inhibited by L-NAME (Duarte and Ferreira, 2000) . In addition, both formalin injection and administration of the glutamate receptor agonist Nmethyl-D-aspartate (NMDA) have been shown to increase the release of NO metabolites in the periphery, and this release was suppressed by the administration of the NO synthase inhibitor N G -monomethyl-L-arginine or the NMDA receptor antagonist D,L-2-amino-5-phosphonovaleric acid (Omote et al., 2000) . It has therefore been suggested that the NO contributes to hyperalgesia by activating the spinal NO/cyclic GMP pathway and that this release of NO is mediated via the activation of the NMDA receptor in the periphery (Omote et al., 2000) .
The non-selective inhibitor L G -nitro-L-arginine and the nNOS selective inhibitor 7-nitroindazole administered intraperitoneally both potentiated the antinociceptive action of paracetamol in rats subjected to the paw pressure, whereas the iNOS inhibitor L-N 6 (1-iminoethyl)lysine had no effect (Bujalska and Gumulka, 2001) . Central administration of 4 L-NAME also potentiated the antinociceptive effect of paracetamol and it was concluded that nNOS may be involved in both the peripheral and the central action of paracetamol (Bujalska, 2003) . The inhibition by paracetamol of NMDA or substance P-induced hyperalgesia was attenuated by the administration of the NO synthase substrate Larginine, indicating that paracetamol may inhibit the NMDA-NO pathway (Bjorkman, 1994) .
These findings suggest that the analgesic action of paracetamol could be partially mediated through the inhibition of NO synthesis in the spinal cord. The aim of this study was therefore to determine directly whether paracetamol inhibited NOS in the spinal cord. We have shown antinociceptive effects of paracetamol in both spinal and supraspinal pain tests in the mouse (Godfrey et al., 2006) and also binding of (Godfrey et al., 2005) , so we chose the mouse as our experimental model for these studies. We also looked at the effect on NO synthesis of caffeine alone and in combination with paracetamol, because of the widespread use of paracetamol/caffeine combinations as over-the-counter analgesics.
Materials and Methods
CD1 male mice (10 day old, 6 per experiment) were killed by decapitation and the brains and spinal cords rapidly removed. Adult mice were not used in these studies because in pilot experiments we were unable to detect NOS activity in response to drug treatment.
The cerebella and spinal cord were dissected free, washed in magnesium-free, ice-cold Krebs buffer (composition (mM) NaCl, 118; KCl, 4.7; KH 2 PO 4, 1.2; NaHCO 3 , 25.0; glucose, 11.0 and CaCl 2, 2.0, continuously gassed with 95% O 2 /5% CO 2 ) and immediately cross-chopped (0.4 mm × 0.4 mm) on a McIlwain tissue chopper. Tissue slices were suspended in 250 ml buffer, and incubated at 37 °C for 15 min. The buffer was then decanted off and replaced with fresh buffer and incubated at 37 °C for a further 5 60 min to allow the slices to equilibrate. The slices were then allowed to settle under gravity, the buffer decanted off and fresh buffer added. This washing step was carried out twice. The slices were then allowed to settle and 50 µl of packed slices were transferred to 5 ml polypropylene tubes containing 200µl Krebs buffer and 30 µl buffer (drug vehicle) or test substance (final concentrations: 100 µM L-NAME, 100 µM paracetamol, 30 µM caffeine or 100 µM paracetamol + 30 µM caffeine, total vol. 280 µl).
Tubes were gassed, capped and incubated at 37 °C for 15 min. Glutamate (5 mM) plus glycine (10 µM) or an equal vol. of buffer were then added to the relevant tubes prior to the addition of [ 3 H]L-arginine (3 µCi/ml, 20µl) giving a final vol. of 330 µl. The tubes were then gassed and capped and incubated at 37 °C for a further 15 min.
The assay was terminated by the addition of 750 µl ice-cold Krebs buffer containing 4 mM EDTA/5 mM L-arginine, and then centrifuged (4,000 × g at 4 °C for 5 min). The pellet was then resuspended in 1 ml of ice-cold 1M trichloroacetic acid, the samples were centrifuged (4,000 × g at 4 °C for 5 min) and the supernatant was removed.
Trichloroacetic acid was extracted three times with 2 ml of water-saturated diethyl ether and then neutralised with 2 ml of 20 mM HEPES buffer (pH 6.0). The neutralized samples were applied to 2 ml columns of Dowex AG50WX-8 (Na + form), eluted with 2 ml of distilled water and [ 3 H]citrulline in the eluate was quantified by liquid scintillation spectroscopy.
Results were expressed as disintegrations per minute (dpm) of [ 3 H]citrulline (mean ± S.E.M). Statistical analysis was performed by one-way ANOVA (for the factor treatment), followed by Scheffe's post hoc test. L-arginine, EDTA, L-NAME, L-glutamate, paracetamol and caffeine were obtained from Sigma Aldrich (Dorset, UK). NaOH, glucose, and glycine were obtained from VWR International (Lutterworth, UK). All other chemicals were purchased from Fisher Scientific (Loughborough, UK). All drugs were made up in magnesium-free Krebs bicarbonate buffer.
Results

NO synthase activity in cerebellar slices
The basal production of [ 3 H]citrulline in cerebella from 10 day old mice was 2768 ± 110 dpm (n=5). Glutamate (5 mM) plus glycine (10 µM) significantly increased the production of [ 3 H]citrulline, which was abolished by preincubation with L-NAME (100 µM). L-NAME (100 µM) alone did not alter the basal production of [ 3 H]citrulline.
Paracetamol (100 µM) did not alter the basal production of [ 3 H]citrulline and had no effect on the glutamate/glycine-induced increase (Fig 1A) .
NO synthase activity in spinal cord slices
The basal production of [ 3 H]citrulline in spinal cord slices from 10 day old mice was 625 ± 107 dpm (n=7). L-NAME (100 µM), paracetamol (100 µM) and caffeine (30 µM) alone or in combination did not alter the basal production of [ 3 H]citrulline. Glutamate (5 mM) plus glycine (10 µM) produced a significant increase in production of [ 3 H]citrulline, which was significantly attenuated by preincubation with L-NAME (100 µM). In the presence of either paracetamol (100 µM) or caffeine (30 µM) there was no significant stimulation of [ 3 H]citrulline production by glutamate (5 mM) plus glycine (10 µM),
showing an attenuation by these drugs of glutamate/glycine-induced NO synthesis. There was a further reduction in [ 3 H]citrulline production when the drugs were added together, 7 and a significant difference between glutamate plus glycine alone and glutamate plus glycine in the presence of a combination of paracetamol (100 µM) and caffeine (30 µM) (Fig 1B) .
Discussion
The mechanism of NO synthesis and its inhibition has previously been studied in the cerebellum of 10 day old rat pups (Bredt and Snyder, 1989; Garthwaite et al., 1989; Toms and Roberts, 1994) as high levels of nNOS are observed in this tissue at this age. NOS activity in the cord has not been previously measured using the stoichiometric conversion of [ 3 H]arginine to [ 3 H]citrulline, so the cerebellum was also used as a brain model of NOS activity to validate the method. The concentration of paracetamol (100 µM) was chosen to reflect peak plasma concentrations following administration of 10-20 mg/kg paracetamol in vivo, equivalent to a dose of less that 1 g of paracetamol in man and therefore within the therapeutic range (Prescott, 2001 ). The concentration of caffeine (30 µM) was chosen to be within the range selective for adenosine receptor blockade and equivalent to a dose of around 7 mg/kg, a dose at the high end of those which could be achieved in man (Fredholm et al., 1996) . In each case these doses are similar to those that we have previously used in in vivo studies in mice (10-200 mg/kg paracetamol, 10 mg/kg caffeine (Godfrey et al., 2006) . While previous studies have reported that caffeine enhances the antinociceptive effect of paracetamol in mice, rats and humans (Laska et al., 1983; Granados-Soto et al., 1993; Engelhardt et al., 1997) , we found instead that caffeine can inhibit the antinociceptive effects of paracetamol in mice (Godfrey et al., 2006) . This discrepancy may reflect the fact that caffeine is a non-selective adenosine receptor antagonist and that blockade of adenosine A 1 and A 2A receptors may have opposing effects on pain pathways.
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In agreement with Bredt & Snyder (1989) , glutamate (5 mM) plus glycine (10 µM) produced a robust increase (85 % increase relative to control) in NOS activity in cerebellar slices from 10 day old mice. Preincubation with L-NAME (100 µM)
completely abolished the glutamate/glycine-induced stimulation showing that this method was sensitive enough to detect a possible reduction in NO production by paracetamol.
However, paracetamol failed to influence significantly either basal or glutamate/glycineinduced NOS activity in neonatal mouse cerebellar slices. This is in agreement with a brief report by Raffa (2002) who found no evidence that paracetamol (0.01-10 mM) directly inhibited nNOS in the rat cerebellum.
Basal production of NO was significantly stimulated (185 % increase relative to control)
in the presence of glutamate (5 mM)/glycine (10 µM) in spinal cord slices from 10 day old mice. This stimulation was also significantly attenuated by L-NAME as in the cerebellum. In contrast to the cerebellum, paracetamol (100 µM) attenuated the glutamate/glycine-induced synthesis of NO, but had no effect on the basal release of NO.
The reason for the different effect of paracetamol on NO production in the two sites is unclear. Caffeine (30 µM) also had no effect on basal production but attenuated the glutamate/glycine-induced stimulation. In the rat hippocampus adenosine A 1 receptor stimulation has been shown to inhibit both basal and NMDA-induced synthesis of NO, (Bhardwaj et al., 1995) , so adenosine A 1 receptor antagonism might be expected to potentiate NO synthesis. However, in our experiments caffeine attenuated NO production, suggesting instead an action via adenosine A 2 receptor antagonism.
When paracetamol (100 µM) and caffeine (30 µM) together were preincubated with spinal cord slices they significantly inhibited the glutamate/glycine-induced stimulation to a greater extent than the paracetamol or caffeine alone. This enhancement by caffeine of the effects of paracetamol is similar to the reported enhancement by caffeine of the analgesic effects of paracetamol (Laska et al., 1983; Granados-Soto et al., 1993; 9 Engelhardt et al., 1997) , although from the results presented here it cannot be concluded that the inhibition of NO synthesis is responsible for these analgesic effects. However, our direct demonstration of the inhibition of spinal cord NO synthesis by paracetamol supports the suggestion made by Bjorkman (1994) on the basis of behavioural studies that the analgesic effect of paracetamol is partly through the spinal inhibition of hyperalgesia-induced NO release.
In conclusion, in the mouse cerebellum and spinal cord glutamate/glycine induced the generation of NO. Paracetamol and caffeine either alone or in combination did not affect the basal synthesis of NO but attenuated glutamate/glycine-induced NO synthesis in the spinal cord but not the cerebellum. It is also apparent that caffeine enhanced the inhibitory effect of paracetamol on NO production in the spinal cord.
